Melphalan Synthesis Using 1,3,2-Dioxathiolane 2,2-Dioxide
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthesis processes for Melphalan require the use of ethylene oxide, which poses safety concerns, especially at an industrial scale.
Innovation Solution
A process involving the regiospecific bis sulfate-alkylation of the aromatic amino group of 4-amino-L-phenylalanine using 1,3,2-dioxathiolane 2,2-dioxide to introduce -N(CH2CH2OS(O)nO-2 groups, followed by conversion to -N(CH2CH2Cl)2 groups, avoiding ethylene oxide and using safer, more manageable reagents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If ethylene oxide is used for hydroxyethylation of the amino group, then the synthesis of Melphalan can be achieved, but safety concerns arise especially at industrial scale
Solution Approach 1:
The patent uses ethylene sulfate as an intermediary reagent to achieve the hydroxyethylation of the amino group. Instead of directly using ethylene oxide, the process employs ethylene sulfate which reacts with the amino group to form a sulfate ester intermediate, which is then converted to the final chloroethyl product. This intermediary approach eliminates the safety hazards of ethylene oxide while maintaining the synthetic utility.
Solution Approach 2:
The patent changes the physical and chemical parameters of the alkylating agent. Instead of using ethylene oxide (a gaseous, highly reactive compound), the invention uses ethylene sulfate (a liquid, less hazardous compound). This parameter change from gas to liquid phase, and from highly reactive to moderately reactive, maintains the alkylating capability while dramatically improving safety for industrial-scale operations.
2Ease of manufacture
If ethylene oxide is used as alkylating agent, then the desired alkylation reaction occurs, but hazardous reagents are introduced into the process
Solution Approach 1:
The patent introduces ethylene sulfate as a safer intermediary reagent that performs the same alkylating function as ethylene oxide. The ethylene sulfate reacts with the amino group to form an intermediate sulfate ester, which is then converted to the final product. This intermediary approach maintains reaction effectiveness while eliminating the hazardous nature of ethylene oxide.
Solution Approach 2:
The patent employs a reagent system where ethylene sulfate serves as a disposable, less hazardous alternative to ethylene oxide. The ethylene sulfate is consumed in the reaction to form the desired product, and its hazardous waste profile is significantly reduced compared to ethylene oxide, making it more suitable for industrial manufacturing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method eliminates the use of ethylene oxide, reduces safety risks, and uses less hazardous reagents, providing a safer and more efficient synthesis of optically pure L-Melphalan.
Implementation Method 1
the regiosspecific bis sulfate-alkylation of the aromatic amino group of 4-amino-L-phenylalanine using 1,3,2-dioxathiolane 2,2-dioxide to introduce -N(CH2CH2OS(O)nO-2 groups
Implementation Method 2
followed by conversion to -N(CH2CH2Cl)2 groups
Data Source
AI summary
The invention relates to a process for the preparation of Melphalan (4-[bis(2-5 chloroethyl)amino]-L-phenylalanine of formula (I) said process comprising the reaction of a 4-amino-L-phenylalanine protected at the carboxy and amino aminoacidic groups with an agent able to convert the aromatic amino group into a group of formula: -N(CH2CH2OS(O)nO-)2, wherein n is 1 or 2 followed by conversion of the –-N(CH2CH2OS(O)nO-)2 group into a -N(CH2CH2Cl)2 group. The invention also provides novel intermediates useful for the preparation of Melphalan.